DWA
DMAC icon

Dorsey Wright & Associates’s DiaMedica Therapeutics DMAC Stock Holding History

Dorsey Wright & Associates’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,937
Closed -$36K – 315
2021
Q1 		$36K Buy
+3,937
New +$36.8K 0.42% 126

Other funds holding DMAC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
JAMONY
Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dorsey Wright & Associates's DMAC Position: Q2 2021 in Review

Dorsey Wright & Associates sold out of DiaMedica Therapeutics (DMAC) in Q2 2021, closing a stake of 3,937 shares — an estimated $36K sold.

Dorsey Wright & Associates first reported a position in DMAC in Q1 2021 and held it in 1 quarter. The position peaked at $36K in Q1 2021. 43 funds tracked by Wall St. Rank hold DMAC as of Q2 2021.

  • Dorsey Wright & Associates reported no remaining DiaMedica Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Dorsey Wright & Associates sold 3,937 DiaMedica Therapeutics shares in Q2 2021, an estimated $36K.
  • Dorsey Wright & Associates first reported a position in DiaMedica Therapeutics in Q1 2021 and held it in 1 quarter.
  • Dorsey Wright & Associates's DiaMedica Therapeutics position peaked at $36K in Q1 2021.
  • 43 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q2 2021.

Based on Dorsey Wright & Associates's 13F filing for Q2 2021, filed 23 Jul 2021.